Mr. Speaker, in her speech, my colleague quite pointedly criticized various aspects of this bill. She explained why it should not be passed.
In my opinion, she left out one thing, and that was jurisdictions. It is not the federal government's place to become involved in health issues or, by extension, in drug management.
Does my colleague have anything to add about the federal government's jurisdiction over pharmacare?